Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Olema Pharmaceuticals Inc (NASDAQ: OLMA)

 
OLMA Technical Analysis
5
As on 18th Nov 2025 OLMA SHARE Price closed @ 20.14 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 9.01 & Strong Buy for SHORT-TERM with Stoploss of 12.83 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

OLMASHARE Price

Open 26.45 Change Price %
High 27.17 1 Day 11.62 136.38
Low 18.11 1 Week 11.79 141.20
Close 20.14 1 Month 9.70 92.91
Volume 86885164 1 Year 10.46 108.06
52 Week High 16.46 | 52 Week Low 3.06
 
NASDAQ USA Most Active Stocks
LPTX 2.05 365.91%
AMRS 0.14 100.00%
WBA 11.98 0.50%
NVDA 181.36 -2.81%
ONDS 7.84 25.44%
PLUG 2.14 2.88%
OPEN 7.52 -4.08%
LMDX 0.02 0.00%
AKTS 0.04 0.00%
OLMA 20.14 136.38%
 
NASDAQ USA Top Gainers Stocks
MRIN 3450.00 383233.34%
MRIN 3450.00 383233.34%
KTRA 6.30 2763.64%
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
LPTX 2.05 365.91%
NDRAW 0.03 200.00%
HCVIU 9.00 159.37%
GLSPT 33.43 138.62%
 
NASDAQ USA Top Losers Stocks
COMSP 0.00 -100.00%
FPAY 0.01 -94.74%
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
SWSSU 1.06 -89.40%
ZIVOW 0.06 -85.00%
ORGS 0.15 -83.52%
OTRK 0.07 -78.79%
ACAQ-UN 2.50 -73.49%
AGBA 0.35 -71.31%
 
 
OLMA
Daily Charts		 OLMA
Intraday Charts		 Whats New @
Bazaartrend		 OLMA
Free Analysis
 
OLMA Important Levels Intraday
RESISTANCE37.60
RESISTANCE32.00
RESISTANCE28.54
RESISTANCE25.08
SUPPORT15.20
SUPPORT11.74
SUPPORT8.28
SUPPORT2.68
 
OLMA Forecast November 2025
Share
4th UP Forecast32.61
3rd UP Forecast28.61
2nd UP Forecast26.14
1st UP Forecast23.67
1st DOWN Forecast16.61
2nd DOWN Forecast14.14
3rd DOWN Forecast11.67
4th DOWN Forecast7.67
 
OLMA Weekly Forecast
4th UP Forecast27.06
3rd UP Forecast24.84
2nd UP Forecast23.47
1st UP Forecast22.10
1st DOWN Forecast18.18
2nd DOWN Forecast16.81
3rd DOWN Forecast15.44
4th DOWN Forecast13.22
 
OLMA Forecast2025
4th UP Forecast66.99
3rd UP Forecast51.96
2nd UP Forecast42.68
1st UP Forecast33.39
1st DOWN Forecast6.89
2nd DOWN Forecast-2.4
3rd DOWN Forecast-11.68
4th DOWN Forecast-26.71
 
 
OLMA Other Details
Segment EQ
Market Capital 1073203072.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
OLMA Address
OLMA
 
OLMA Latest News
 
Your Comments and Response on Olema Pharmaceuticals Inc
 
OLMA Business Profile
Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, locally advanced, or metastatic estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer. The company was formerly known as CombiThera, Inc. and changed its name to Olema Pharmaceuticals, Inc. in March 2009. Olema Pharmaceuticals, Inc. was incorporated in 2006 and is headquartered in San Francisco, California. Address: 512 2nd Street, San Francisco, CA, United States, 94107
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service